Table 4:
Risk factors associated with thromboembolic complications
| Odds Ratio | 95% Wald CI | P Value | |
|---|---|---|---|
| Sex | 0.736 | 0.220–2.467 | .620 |
| Age | 0.999 | 0.945–1.056 | .972 |
| Hypertension | 1.652 | 0.479–5.703 | .427 |
| Smoking | 0.881 | 0.265–2.926 | .836 |
| Previous stroke/TIA | 2.039 | 0.493–8.427 | .325 |
| Dyslipidemia | 1.350 | 0.409–4.458 | .622 |
| Prior antithrombotic usage | 0.344 | 0.108–1.098 | .072 |
| Aneurysm presentation | |||
| Unruptured, symptomatic | 0.914 | 0.159–5.265 | .920 |
| Recurrent or residual | 0.659 | 0.168–2.581 | .550 |
| Aneurysm location (posterior circulation) | 0.807 | 0.168–2.581 | .774 |
| Aneurysm morphology (fusiform) | 4.878 | 0.885–26.887 | .069 |
| Aneurysm size | 1.037 | 0.955–1.127 | .386 |
| Antiplatelet medication (ticagrelor) | 1.035 | 0.348–3.083 | .950 |
| Treatment technique (flow-diverter) | 1.218 | 0.317–4.676 | .774 |